Innate Pharma S.A.

NASDAQ:IPHA

Biotechnology

Healthcare
$1.03 +1.91%

+$0.03 today

Market cap
$115.05M
Beta
0.89
P/E (TTM)
-3.0
EPS (TTM)
-$0.54
52W Low $1.17High $2.63

Volume 0.50M

Average 0.07M

IPHA Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

Innate Pharma S.A.NASDAQ: IPHA

Operating Expenses · Q4 FY2025 · quarter ended Dec 2025

Operating expenses declines year over year

Q4 FY2025 operating expenses of €46.45M fell 15.0% year over year. Over 3 fiscal years it compounded at -3.9% a year.

Context

  • Operating expenses amounted to 2016.9% of revenue in FY2025, up 1508.3 pp from a year earlier.
  • Operating expenses increased in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterDec 2025
€46.45M— QoQ
Last fiscal yearDec 2025
€56.21M-12.4% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-15.0%——
1 year-12.4%——
3-year CAGR-3.9%——
5-year CAGR——
10-year CAGR——

Operating Expenses history

EUR · from the income statement

Latest · FY2025
56.21M EUR
Year-over-year change
-12.4%
4-year CAGR
+21.8%

Operating Expenses vs competitors

How IPHA compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -12.4% is the 6th highest of 9, against a peer median of +13.1%.
  • Operating expenses amounts to 2016.9% of revenue for IPHA, versus a peer median of 2476.0%.
IPHA Competitors
Operating Expenses for IPHA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CRBPCorbus Pharmaceuticals Holdings, Inc.LTM Mar 2026$89.69M USD+109.1%+36.8%—
MISTMilestone Pharmaceuticals Inc.LTM Mar 2026$67.15M USD+28.8%-0.4%3764.1%
MOLNMolecular Partners AGLTM Mar 2026CHF 63.08M CHF+100.0%-11.3%—
IPHAInnate Pharma S.A.FY2025€56.21M EUR-12.4%-3.9%2016.9%
RANIRani Therapeutics Holdings, Inc.LTM Mar 2026$37.64M USD-28.3%-14.9%1187.9%
ELTXElicio Therapeutics, Inc.LTM Mar 2026$37.29M USD-15.8%+17.3%—
CRDFCardiff Oncology, Inc.LTM Mar 2026$36.37M USD-15.3%+7.1%6928.2%
CGENCompugen Ltd.LTM Mar 2026$33.28M USD-2.6%-8.4%45.8%
NVCTNuvectis Pharma, Inc.LTM Mar 2026$28.27M USD+34.5%+12.8%—
Peer median (excluding IPHA) —+13.1%+3.4%2476.0%

Competitors are the stored peer set for IPHA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue12.11M57.67M51.9M12.62M2.79M
Cost of Revenue47M51.66M56.02M51.98M0
Gross Profit(22.3M)6.01M5.62M12.62M2.79M
Gross Margin-184.1%10.4%10.8%100.0%100.0%
Research & Development47M51.66M56.02M51.98M43.62M
Selling, General & Admin25.52M14.47M11.75M11.93M11M
Operating Expenses25.52M63.44M18.29M64.2M56.21M
Depreciation & Amortization4.6M45.41M5.09M1.99M5.09M
EBITDA(43.23M)(12.28M)(1.84M)(46.91M)(43.65M)
EBITDA Margin-356.9%-21.3%-3.5%-371.7%-1566.1%
Operating Income(47.83M)(57.43M)(12.67M)(51.58M)(53.43M)
Operating Margin-394.9%-99.6%-24.4%-408.6%-1916.9%
Interest Income327K546K3.18M2.44M1.32M
Interest Expense312K288K640K566K440K
Other Income / Expenses2.35M(547K)5.1M2.1M4.25M
Income Before Tax(45.48M)(57.97M)(7.57M)(49.47M)(49.18M)
Pre-Tax Margin-375.5%-100.5%-14.6%-392.0%-1764.5%
Income Tax Expense00000
Net Income(52.81M)(58.1M)(7.57M)(49.47M)(49.18M)
Net Margin-436.0%-100.7%-14.6%-392.0%-1764.5%
EPS (Basic)(0.57)(0.73)(0.09)(0.61)(0.53)
EPS (Diluted)(0.57)(0.73)(0.09)(0.61)(0.53)
Weighted Avg Shares79.54M79.59M84.11M81.05M89.42M
Weighted Avg Shares (Diluted)79.54M79.64M84.11M81.05M89.42M

Innate Pharma S.A.

NASDAQ:IPHA

Intrinsic Alpha fair value

Locked

Current Price

$1.03

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.